Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q56508213
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000331.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q56508213
|
024
|
|
|
‡a
0000-0003-2505-2547
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q56508213
|
043
|
|
|
‡c
CA
|
100
|
0 |
|
‡a
Kathryn J. Moore
‡c
Canadian microbiologist
‡9
en
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
ক্যাথরিন জে মুর
‡9
bn
|
400
|
0 |
|
‡a
Kathryn J Moore
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A big role for small RNAs in HDL homeostasis.
|
670
|
|
|
‡a
Author's A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid.
|
670
|
|
|
‡a
Author's A heritable netrin-1 mutation increases atherogenic immune responses
|
670
|
|
|
‡a
Author's A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36.
|
670
|
|
|
‡a
Author's A regulator of secretory vesicle size, Kelch-like protein 12, facilitates the secretion of apolipoprotein B100 and very-low-density lipoproteins--brief report
|
670
|
|
|
‡a
Author's Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels.
|
670
|
|
|
‡a
Author's Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function
|
670
|
|
|
‡a
Author's An Eclectic Cast of Cellular Actors Orchestrates Innate Immune Responses in the Mechanisms Driving Obesity and Metabolic Perturbation
|
670
|
|
|
‡a
Author's Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
|
670
|
|
|
‡a
Author's Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress
|
670
|
|
|
‡a
Author's Atherosclerosis and innate immune signaling.
|
670
|
|
|
‡a
Author's ATP-binding cassette transporter A1 contains an NH2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space.
|
670
|
|
|
‡a
Author's beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins
|
670
|
|
|
‡a
Author's CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
|
670
|
|
|
‡a
Author's CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
|
670
|
|
|
‡a
Author's CD36 mediates the innate host response to beta-amyloid
|
670
|
|
|
‡a
Author's CD36 signals to the actin cytoskeleton and regulates microglial migration via a p130Cas complex.
|
670
|
|
|
‡a
Author's Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells
|
670
|
|
|
‡a
Author's Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis and Atherogenesis.
|
670
|
|
|
‡a
Author's Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype
|
670
|
|
|
‡a
Author's Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages.
|
670
|
|
|
‡a
Author's Commentary on fatty acid wars: the diffusionists versus the translocatists.
|
670
|
|
|
‡a
Author's Connecting Transcriptional and Functional Macrophage Heterogeneity in Atherosclerosis
|
670
|
|
|
‡a
Author's COVID-19 and the Heart and Vasculature: Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease
|
670
|
|
|
‡a
Author's Crosstalk Between the Heart and Cancer: Beyond Drug Toxicity
|
670
|
|
|
‡a
Author's Defining Macrophages in the Heart One Cell at a Time
|
670
|
|
|
‡a
Author's Deletion of ABCA1 and ABCG1 impairs macrophage migration because of increased Rac1 signaling
|
670
|
|
|
‡a
Author's Designer macrophages: oxidative metabolism fuels inflammation repair
|
670
|
|
|
‡a
Author's Divergent response to LPS and bacteria in CD14-deficient murine macrophages.
|
670
|
|
|
‡a
Author's Dysfunctional HDL takes its toll in chronic kidney disease
|
670
|
|
|
‡a
Author's eLiXiRs for restraining inflammation
|
670
|
|
|
‡a
Author's Emerging Roles of PCSK9: More Than a One-Trick Pony.
|
670
|
|
|
‡a
Author's Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions
|
670
|
|
|
‡a
Author's Enhanced glycolysis and HIF-1α activation in adipose tissue macrophages sustains local and systemic interleukin-1β production in obesity
|
670
|
|
|
‡a
Author's Erratum: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|
670
|
|
|
‡a
Author's Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36
|
670
|
|
|
‡a
Author's Fibrillar amyloid protein present in atheroma activates CD36 signal transduction.
|
670
|
|
|
‡a
Author's HDL and cardiovascular risk: time to call the plumber?
|
670
|
|
|
‡a
Author's HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages
|
670
|
|
|
‡a
Author's HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells
|
670
|
|
|
‡a
Author's Heat shock protein-27 attenuates foam cell formation and atherogenesis by down-regulating scavenger receptor-A expression via NF-κB signaling
|
670
|
|
|
‡a
Author's High-density lipoproteins put out the fire
|
670
|
|
|
‡a
Author's Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival
|
670
|
|
|
‡a
Author's IL-1 signaling in atherosclerosis: sibling rivalry
|
670
|
|
|
‡a
Author's IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages
|
670
|
|
|
‡a
Author's Immune cell screening of a nanoparticle library improves atherosclerosis therapy
|
670
|
|
|
‡a
Author's In vitro-differentiated embryonic stem cell macrophages: a model system for studying atherosclerosis-associated macrophage functions
|
670
|
|
|
‡a
Author's Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression
|
670
|
|
|
‡a
Author's Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment
|
670
|
|
|
‡a
Author's Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.
|
670
|
|
|
‡a
Author's Introduction to the Obesity, Metabolic Syndrome, and CVD Compendium
|
670
|
|
|
‡a
Author's Lack of lymphatic vessel phenotype in LYVE-1/CD44 double knockout mice.
|
670
|
|
|
‡a
Author's LDL Receptor Pathway Regulation by miR-224 and miR-520d
|
670
|
|
|
‡a
Author's Leishmania amazonensis Engages CD36 to Drive Parasitophorous Vacuole Maturation
|
670
|
|
|
‡a
Author's Leukocyte Heterogeneity in Adipose Tissue, Including in Obesity
|
670
|
|
|
‡a
Author's Local Anti-miR Delivery: The Latest in the Arsenal of Drug-Eluting Stents.
|
670
|
|
|
‡a
Author's Long non-coding RNAs regulating macrophage functions in homeostasis and disease
|
670
|
|
|
‡a
Author's Long noncoding RNAs in lipid metabolism.
|
670
|
|
|
‡a
Author's Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
|
670
|
|
|
‡a
Author's Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice
|
670
|
|
|
‡a
Author's LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2.
|
670
|
|
|
‡a
Author's Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapy.
|
670
|
|
|
‡a
Author's Macrophage-derived netrin-1 promotes abdominal aortic aneurysm formation by activating MMP3 in vascular smooth muscle cells
|
670
|
|
|
‡a
Author's Macrophage Foam Cell Formation: The Pathways to Cholesterol Engorgement
|
670
|
|
|
‡a
Author's Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis
|
670
|
|
|
‡a
Author's Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2)
|
670
|
|
|
‡a
Author's Macrophages, atherosclerosis and the potential of netrin-1 as a novel target for future therapeutic intervention
|
670
|
|
|
‡a
Author's Macrophages in atherosclerosis: a dynamic balance.
|
670
|
|
|
‡a
Author's Macrophages in the pathogenesis of atherosclerosis
|
670
|
|
|
‡a
Author's Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome
|
670
|
|
|
‡a
Author's MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis
|
670
|
|
|
‡a
Author's MicroRNA-33 Inhibits Adaptive Thermogenesis and Adipose Tissue Beiging
|
670
|
|
|
‡a
Author's microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis
|
670
|
|
|
‡a
Author's MicroRNA control of high-density lipoprotein metabolism and function
|
670
|
|
|
‡a
Author's MicroRNA modulation of cholesterol homeostasis
|
670
|
|
|
‡a
Author's MicroRNA Regulation of Atherosclerosis
|
670
|
|
|
‡a
Author's microRNAs and cholesterol metabolism
|
670
|
|
|
‡a
Author's MicroRNAs in lipid metabolism
|
670
|
|
|
‡a
Author's MicroRNAs regulating lipid metabolism in atherogenesis
|
670
|
|
|
‡a
Author's microRNAs: small regulators with a big impact on lipid metabolism.
|
670
|
|
|
‡a
Author's MiR-33 contributes to the regulation of cholesterol homeostasis.
|
670
|
|
|
‡a
Author's miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques
|
670
|
|
|
‡a
Author's miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
|
670
|
|
|
‡a
Author's miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.
|
670
|
|
|
‡a
Author's miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux
|
670
|
|
|
‡a
Author's Modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type C57BL/6 mice
|
670
|
|
|
‡a
Author's Molecular Pathways Underlying Cholesterol Homeostasis.
|
670
|
|
|
‡a
Author's Monocyte Adhesion and Plaque Recruitment During Atherosclerosis Development Is Regulated by the Adapter Protein Chat-H/SHEP1
|
670
|
|
|
‡a
Author's Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism
|
670
|
|
|
‡a
Author's Mycobacterium tuberculosis Limits Host Glycolysis and IL-1β by Restriction of PFK-M via MicroRNA-21
|
670
|
|
|
‡a
Author's MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4.
|
670
|
|
|
‡a
Author's Myocardial infarction accelerates breast cancer via innate immune reprogramming
|
670
|
|
|
‡a
Author's Netrin-1 Alters Adipose Tissue Macrophage Fate and Function in Obesity
|
670
|
|
|
‡a
Author's Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis
|
670
|
|
|
‡a
Author's Netrin-1 inhibits leukocyte migration in vitro and in vivo.
|
670
|
|
|
‡a
Author's Netrin-1 is a critical autocrine/paracrine factor for osteoclast differentiation
|
670
|
|
|
‡a
Author's Netrin-1 is highly expressed and required in inflammatory infiltrates in wear particle-induced osteolysis.
|
670
|
|
|
‡a
Author's Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity.
|
670
|
|
|
‡a
Author's Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention
|
670
|
|
|
‡a
Author's NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|
670
|
|
|
‡a
Author's Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association
|
670
|
|
|
‡a
Author's Nuclear hormone receptors and cholesterol trafficking: the orphans find a new home
|
670
|
|
|
‡a
Author's Oxidation of low-density lipoproteins induces amyloid-like structures that are recognized by macrophages.
|
670
|
|
|
‡a
Author's Phagocytosis and phagosome acidification are required for pathogen processing and MyD88-dependent responses to Staphylococcus aureus
|
670
|
|
|
‡a
Author's Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis
|
670
|
|
|
‡a
Author's Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages
|
670
|
|
|
‡a
Author's PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro
|
670
|
|
|
‡a
Author's PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
|
670
|
|
|
‡a
Author's Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways
|
670
|
|
|
‡a
Author's Regulation of macrophage immunometabolism in atherosclerosis
|
670
|
|
|
‡a
Author's Regulation of Stress Granule Formation by Inflammation, Vascular Injury, and Atherosclerosis
|
670
|
|
|
‡a
Author's Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression
|
670
|
|
|
‡a
Author's Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis
|
670
|
|
|
‡a
Author's Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain
|
670
|
|
|
‡a
Author's Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.
|
670
|
|
|
‡a
Author's Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice
|
670
|
|
|
‡a
Author's Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells
|
670
|
|
|
‡a
Author's Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages
|
670
|
|
|
‡a
Author's Scavenger receptors in atherosclerosis: beyond lipid uptake
|
670
|
|
|
‡a
Author's Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI.
|
670
|
|
|
‡a
Author's Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications
|
670
|
|
|
‡a
Author's Single-Cell RNA Sequencing of Visceral Adipose Tissue Leukocytes Reveals that Caloric Restriction Following Obesity Promotes the Accumulation of a Distinct Macrophage Population with Features of Phagocytic Cells
|
670
|
|
|
‡a
Author's Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics.
|
670
|
|
|
‡a
Author's Small RNA overcomes the challenges of therapeutic targeting of microsomal triglyceride transfer protein
|
670
|
|
|
‡a
Author's Store-Operated Ca2+ Entry Controls Induction of Lipolysis and the Transcriptional Reprogramming to Lipid Metabolism
|
670
|
|
|
‡a
Author's Targeting inflammation in CVD: advances and challenges
|
670
|
|
|
‡a
Author's Targeting Innate Immunity for CV Benefit
|
670
|
|
|
‡a
Author's The double-edged sword of fibronectin in atherosclerosis
|
670
|
|
|
‡a
Author's The long noncoding RNA CHROME regulates cholesterol homeostasis in primate
|
670
|
|
|
‡a
Author's The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques
|
670
|
|
|
‡a
Author's The plaque "micro" environment: microRNAs control the risk and the development of atherosclerosis.
|
670
|
|
|
‡a
Author's The role of microRNAs in cholesterol efflux and hepatic lipid metabolism.
|
670
|
|
|
‡a
Author's The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.
|
670
|
|
|
‡a
Author's The Semaphorin 3E/PlexinD1 axis regulates macrophage inflammation in obesity
|
670
|
|
|
‡a
Author's Untangling the role of amyloid in atherosclerosis.
|
670
|
|
|
‡a
Author's Using microRNA as an alternative treatment for hyperlipidemia and cardiovascular disease: cardio-miRs in the pipeline
|
670
|
|
|
‡a
Author's Vascular effects of a low-carbohydrate high-protein diet.
|
670
|
|
|
‡a
Author's Vitamin A mediates conversion of monocyte-derived macrophages into tissue-resident macrophages during alternative activation
|
670
|
|
|
‡a
wikidata site links
‡u
https://en.wikipedia.org/wiki/Kathryn_Moore
|
909
|
|
|
‡a
(orcid) 0000000325052547
‡9
1
|
919
|
|
|
‡a
netrin1inhibitsleukocytemigrationinvitroandinvivo
‡A
Netrin-1 inhibits leukocyte migration in vitro and in vivo.
‡9
1
|
919
|
|
|
‡a
vitaminamediatesconversionofmonocytederivedmacrophagesintotissueresidentmacrophagesduringalternativeactivation
‡A
Vitamin A mediates conversion of monocyte-derived macrophages into tissue-resident macrophages during alternative activation
‡9
1
|
919
|
|
|
‡a
usingmicrornaasanalternativetreatmentforhyperlipidemiaandcardiovasculardiseasecardiomirsinthepipeline
‡A
Using microRNA as an alternative treatment for hyperlipidemia and cardiovascular disease: cardio-miRs in the pipeline
‡9
1
|
919
|
|
|
‡a
semaphorin3plexind1axisregulatesmacrophageinflammationinobesity
‡A
The Semaphorin 3E/PlexinD1 axis regulates macrophage inflammation in obesity
‡9
1
|
919
|
|
|
‡a
roleofppargammainmacrophagedifferentiationandcholesteroluptake
‡A
The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.
‡9
1
|
919
|
|
|
‡a
longnoncodingrnachromeregulatescholesterolhomeostasisinprimate
‡A
The long noncoding RNA CHROME regulates cholesterol homeostasis in primate
‡9
1
|
919
|
|
|
‡a
plaquemicroenvironmentmicrornascontroltheriskandthedevelopmentofatherosclerosis
‡A
The plaque "micro" environment: microRNAs control the risk and the development of atherosclerosis.
‡9
1
|
919
|
|
|
‡a
untanglingtheroleofamyloidinatherosclerosis
‡A
Untangling the role of amyloid in atherosclerosis.
‡9
1
|
919
|
|
|
‡a
neuroimmuneguidancecuenetrin1promotesatherosclerosisbyinhibitingtheemigrationofmacrophagesfromplaques
‡A
The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques
‡9
1
|
919
|
|
|
‡a
doubleedgedswordoffibronectininatherosclerosis
‡A
The double-edged sword of fibronectin in atherosclerosis
‡9
1
|
919
|
|
|
‡a
targetinginflammationincvdadvancesandchallenges
‡A
Targeting inflammation in CVD: advances and challenges
‡9
1
|
919
|
|
|
‡a
roleofmicrornasincholesteroleffluxandhepaticlipidmetabolism
‡A
The role of microRNAs in cholesterol efflux and hepatic lipid metabolism.
‡9
1
|
919
|
|
|
‡a
singlecellrnasequencingofvisceraladiposetissueleukocytesrevealsthatcaloricrestrictionfollowingobesitypromotestheaccumulationofadistinctmacrophagepopulationwithfeaturesofphagocyticcells
‡A
Single-Cell RNA Sequencing of Visceral Adipose Tissue Leukocytes Reveals that Caloric Restriction Following Obesity Promotes the Accumulation of a Distinct Macrophage Population with Features of Phagocytic Cells
‡9
1
|
919
|
|
|
‡a
smallrnaovercomesthechallengesoftherapeutictargetingofmicrosomaltriglyceridetransferprotein
‡A
Small RNA overcomes the challenges of therapeutic targeting of microsomal triglyceride transfer protein
‡9
1
|
919
|
|
|
‡a
serumamyloidpcolocalizeswithapolipoproteinsinhumanatheromafunctionalimplications
‡A
Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications
‡9
1
|
919
|
|
|
‡a
selectiveuptakeofhdlcholesterylestersandcholesteroleffluxfrommouseperitonealmacrophagesindependentofsrbi
‡A
Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI.
‡9
1
|
919
|
|
|
‡a
scavengerreceptorcd36mediatesuptakeofhighdensitylipoproteinsinmiceandbyculturedcells
‡A
Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells
‡9
1
|
919
|
|
|
‡a
scavengerreceptorsinatherosclerosisbeyondlipiduptake
‡A
Scavenger receptors in atherosclerosis: beyond lipid uptake
‡9
1
|
919
|
|
|
‡a
roleofscavengerreceptoraandcd36indietinducednonalcoholicsteatohepatitisinhyperlipidemicmice
‡A
Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.
‡9
1
|
919
|
|
|
‡a
responsetostaphylococcusaureusrequirescd36mediatedphagocytosistriggeredbythecoohterminalcytoplasmicdomain
‡A
Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain
‡9
1
|
919
|
|
|
‡a
requirementofjnk2forscavengerreceptoramediatedfoamcellformationinatherogenesis
‡A
Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis
‡9
1
|
919
|
|
|
‡a
regulatorytcellslicensemacrophageproresolvingfunctionsduringatherosclerosisregression
‡A
Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression
‡9
1
|
919
|
|
|
‡a
regulationofmacrophageimmunometabolisminatherosclerosis
‡A
Regulation of macrophage immunometabolism in atherosclerosis
‡9
1
|
919
|
|
|
‡a
pparγisrequiredforthedifferentiationofadiposetissueinvivoandinvitro
‡A
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
‡9
1
|
919
|
|
|
‡a
ppargammaisrequiredforthedifferentiationofadiposetissueinvivoandinvitro
‡A
PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro
‡9
1
|
919
|
|
|
‡a
polyadpribosepolymerase1repressesliver10receptormediatedabca1expressionandcholesteroleffluxinmacrophages
‡A
Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages
‡9
1
|
919
|
|
|
‡a
scavengerreceptorsclassa12andcd36aretheprincipalreceptorsresponsiblefortheuptakeofmodifiedlowdensitylipoproteinleadingtolipidloadinginmacrophages
‡A
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages
‡9
1
|
919
|
|
|
‡a
phagocytosisandphagosomeacidificationarerequiredforpathogenprocessingandmyd88dependentresponsestostaphylococcusaureus
‡A
Phagocytosis and phagosome acidification are required for pathogen processing and MyD88-dependent responses to Staphylococcus aureus
‡9
1
|
919
|
|
|
‡a
neuroimmuneguidancecuesemaphorin3isexpressedinatheroscleroticplaquesandregulatesmacrophageretention
‡A
Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention
‡9
1
|
919
|
|
|
‡a
nlrp3inflammasomesarerequiredforatherogenesisandactivatedbycholesterolcrystals
‡A
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
‡9
1
|
919
|
|
|
‡a
oxidationoflowdensitylipoproteinsinducesamyloidlikestructuresthatarerecognizedbymacrophages
‡A
Oxidation of low-density lipoproteins induces amyloid-like structures that are recognized by macrophages.
‡9
1
|
919
|
|
|
‡a
netrin1promotesadiposetissuemacrophageretentionandinsulinresistanceinobesity
‡A
Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity.
‡9
1
|
919
|
|
|
‡a
netrin1ishighlyexpressedandrequiredininflammatoryinfiltratesinwearparticleinducedosteolysis
‡A
Netrin-1 is highly expressed and required in inflammatory infiltrates in wear particle-induced osteolysis.
‡9
1
|
919
|
|
|
‡a
netrin1isacriticalautocrineparacrinefactorforosteoclastdifferentiation
‡A
Netrin-1 is a critical autocrine/paracrine factor for osteoclast differentiation
‡9
1
|
919
|
|
|
‡a
nuclearhormonereceptorsandcholesteroltraffickingtheorphansfindanewhome
‡A
Nuclear hormone receptors and cholesterol trafficking: the orphans find a new home
‡9
1
|
919
|
|
|
‡a
plateletregulationofmyeloidsuppressorofcytokinesignaling3acceleratesatherosclerosis
‡A
Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis
‡9
1
|
919
|
|
|
‡a
mycobacteriumtuberculosislimitshostglycolysisandil1βbyrestrictionofpfk1000viamicrorna21
‡A
Mycobacterium tuberculosis Limits Host Glycolysis and IL-1β by Restriction of PFK-M via MicroRNA-21
‡9
1
|
919
|
|
|
‡a
netrin1altersadiposetissuemacrophagefateandfunctioninobesity
‡A
Netrin-1 Alters Adipose Tissue Macrophage Fate and Function in Obesity
‡9
1
|
919
|
|
|
‡a
mycobacteriumtuberculosisinducesthemir33locustoreprogramautophagyandhostlipidmetabolism
‡A
Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism
‡9
1
|
919
|
|
|
‡a
micrornasinlipidmetabolism
‡A
MicroRNAs in lipid metabolism
‡9
1
|
919
|
|
|
‡a
micrornasregulatinglipidmetabolisminatherogenesis
‡A
MicroRNAs regulating lipid metabolism in atherogenesis
‡9
1
|
919
|
|
|
‡a
mir33inhibitionovercomesdeleteriouseffectsofdiabetesmellitusonatherosclerosisplaqueregressioninmice
‡A
miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.
‡9
1
|
919
|
|
|
‡a
mir33silencingreprogramstheimmunecelllandscapeinatheroscleroticplaques
‡A
miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques
‡9
1
|
919
|
|
|
‡a
modulationofambienttemperaturepromotesinflammationandinitiatesatherosclerosisinwildtypec57bl6mice
‡A
Modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type C57BL/6 mice
‡9
1
|
919
|
|
|
‡a
mir33abcontributetotheregulationoffattyacidmetabolismandinsulinsignaling
‡A
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
‡9
1
|
919
|
|
|
‡a
monocyteadhesionandplaquerecruitmentduringatherosclerosisdevelopmentisregulatedbytheadapterproteinchathshep1
‡A
Monocyte Adhesion and Plaque Recruitment During Atherosclerosis Development Is Regulated by the Adapter Protein Chat-H/SHEP1
‡9
1
|
919
|
|
|
‡a
microrna33inhibitsadaptivethermogenesisandadiposetissuebeiging
‡A
MicroRNA-33 Inhibits Adaptive Thermogenesis and Adipose Tissue Beiging
‡9
1
|
919
|
|
|
‡a
mirnatargetingofoxysterolbindingproteinlike6regulatescholesteroltraffickingandefflux
‡A
miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux
‡9
1
|
919
|
|
|
‡a
mir33contributestotheregulationofcholesterolhomeostasis
‡A
MiR-33 contributes to the regulation of cholesterol homeostasis.
‡9
1
|
919
|
|
|
‡a
myd88deficiencyattenuatesangiotensin2inducedabdominalaorticaneurysmformationindependentofsignalingthroughtolllikereceptors2and4
‡A
MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4.
‡9
1
|
919
|
|
|
‡a
noncodingrnasincardiovasculardiseasecurrentknowledgetoolsandtechnologiesforinvestigationandfuturedirectionsascientificstatementfromtheamericanheartassociation
‡A
Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association
‡9
1
|
919
|
|
|
‡a
micrornaregulationofatherosclerosis
‡A
MicroRNA Regulation of Atherosclerosis
‡9
1
|
919
|
|
|
‡a
macrophagesinthepathogenesisofatherosclerosis
‡A
Macrophages in the pathogenesis of atherosclerosis
‡9
1
|
919
|
|
|
‡a
mannosebindinglectinenhancestolllikereceptors2and6signalingfromthephagosome
‡A
Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome
‡9
1
|
919
|
|
|
‡a
macrophagesatherosclerosisandthepotentialofnetrin1asanoveltargetforfuturetherapeuticintervention
‡A
Macrophages, atherosclerosis and the potential of netrin-1 as a novel target for future therapeutic intervention
‡9
1
|
919
|
|
|
‡a
macrophagetraffickinginflammatoryresolutionandgenomicsinatherosclerosisjaccmacrophageincvdseriespart2
‡A
Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2)
‡9
1
|
919
|
|
|
‡a
macrophagemitochondrialenergystatusregulatescholesteroleffluxandisenhancedbyantimir33inatherosclerosis
‡A
Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis
‡9
1
|
919
|
|
|
‡a
macrophagefoamcellformationthepathwaystocholesterolengorgement
‡A
Macrophage Foam Cell Formation: The Pathways to Cholesterol Engorgement
‡9
1
|
919
|
|
|
‡a
macrophagederivednetrin1promotesabdominalaorticaneurysmformationbyactivatingmmp3invascularsmoothmusclecells
‡A
Macrophage-derived netrin-1 promotes abdominal aortic aneurysm formation by activating MMP3 in vascular smooth muscle cells
‡9
1
|
919
|
|
|
‡a
macrophagesinatherosclerosisadynamicbalance
‡A
Macrophages in atherosclerosis: a dynamic balance.
‡9
1
|
919
|
|
|
‡a
macrophagederivedfoamcellsinatherosclerosislessonsfrommurinemodelsandimplicationsfortherapy
‡A
Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapy.
‡9
1
|
919
|
|
|
‡a
lxrmediatedabca1expressionandfunctionaremodulatedbyhighglucoseandprmt2
‡A
LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2.
‡9
1
|
919
|
|
|
‡a
lossofreceptormediatedlipiduptakeviascavengerreceptoraorcd36pathwaysdoesnotameliorateatherosclerosisinhyperlipidemicmice
‡A
Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
‡9
1
|
919
|
|
|
‡a
longnoncodingrnasinlipidmetabolism
‡A
Long noncoding RNAs in lipid metabolism.
‡9
1
|
919
|
|
|
‡a
localantimirdeliverythelatestinthearsenalofdrugelutingstents
‡A
Local Anti-miR Delivery: The Latest in the Arsenal of Drug-Eluting Stents.
‡9
1
|
919
|
|
|
‡a
leukocyteheterogeneityinadiposetissueincludinginobesity
‡A
Leukocyte Heterogeneity in Adipose Tissue, Including in Obesity
‡9
1
|
919
|
|
|
‡a
leishmaniaamazonensisengagescd36todriveparasitophorousvacuolematuration
‡A
Leishmania amazonensis Engages CD36 to Drive Parasitophorous Vacuole Maturation
‡9
1
|
919
|
|
|
‡a
microrna33dependentregulationofmacrophagemetabolismdirectsimmunecellpolarizationinatherosclerosis
‡A
MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis
‡9
1
|
919
|
|
|
‡a
micrornacontrolofhighdensitylipoproteinmetabolismandfunction
‡A
MicroRNA control of high-density lipoprotein metabolism and function
‡9
1
|
919
|
|
|
‡a
microrna33regulatesmacrophageautophagyinatherosclerosis
‡A
microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis
‡9
1
|
919
|
|
|
‡a
lossofsraandcd36activityreducesatheroscleroticlesioncomplexitywithoutabrogatingfoamcellformationinhyperlipidemicmice
‡A
Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice
‡9
1
|
919
|
|
|
‡a
micrornamodulationofcholesterolhomeostasis
‡A
MicroRNA modulation of cholesterol homeostasis
‡9
1
|
919
|
|
|
‡a
molecularpathwaysunderlyingcholesterolhomeostasis
‡A
Molecular Pathways Underlying Cholesterol Homeostasis.
‡9
1
|
919
|
|
|
‡a
micrornasandcholesterolmetabolism
‡A
microRNAs and cholesterol metabolism
‡9
1
|
919
|
|
|
‡a
introductiontotheobesitymetabolicsyndromeandcvdcompendium
‡A
Introduction to the Obesity, Metabolic Syndrome, and CVD Compendium
‡9
1
|
919
|
|
|
‡a
micrornassmallregulatorswithabigimpactonlipidmetabolism
‡A
microRNAs: small regulators with a big impact on lipid metabolism.
‡9
1
|
919
|
|
|
‡a
longnoncodingrnasregulatingmacrophagefunctionsinhomeostasisanddisease
‡A
Long non-coding RNAs regulating macrophage functions in homeostasis and disease
‡9
1
|
919
|
|
|
‡a
lackoflymphaticvesselphenotypeinlyve1cd44doubleknockoutmice
‡A
Lack of lymphatic vessel phenotype in LYVE-1/CD44 double knockout mice.
‡9
1
|
919
|
|
|
‡a
inhibitionofmir33abinnonhumanprimatesraisesplasmahdlandlowersvldltriglycerides
‡A
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.
‡9
1
|
919
|
|
|
‡a
inflammatoryly6chimonocytesandtheirconversiontom2macrophagesdriveatherosclerosisregression
‡A
Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression
‡9
1
|
919
|
|
|
‡a
invitrodifferentiatedembryonicstemcellmacrophagesamodelsystemforstudyingatherosclerosisassociatedmacrophagefunctions
‡A
In vitro-differentiated embryonic stem cell macrophages: a model system for studying atherosclerosis-associated macrophage functions
‡9
1
|
919
|
|
|
‡a
immunecellscreeningofananoparticlelibraryimprovesatherosclerosistherapy
‡A
Immune cell screening of a nanoparticle library improves atherosclerosis therapy
‡9
1
|
919
|
|
|
‡a
highdensitylipoproteinsputoutthefire
‡A
High-density lipoproteins put out the fire
‡9
1
|
919
|
|
|
‡a
inhibitionofatherogenesisinblt1deficientmicerevealsaroleforltb4andblt1insmoothmusclecellrecruitment
‡A
Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment
‡9
1
|
919
|
|
|
‡a
netrin1anditsreceptorunc5barenoveltargetsforthetreatmentofinflammatoryarthritis
‡A
Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis
‡9
1
|
919
|
|
|
‡a
fibrillaramyloidproteinpresentinatheromaactivatescd36signaltransduction
‡A
Fibrillar amyloid protein present in atheroma activates CD36 signal transduction.
‡9
1
|
919
|
|
|
‡a
hypoxiainducesnetrin1andunc5binatheroscleroticplaquesmechanismformacrophageretentionandsurvival
‡A
Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival
‡9
1
|
919
|
|
|
‡a
hdlmimeticplgananoparticletotargetatherosclerosisplaquemacrophages
‡A
HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages
‡9
1
|
919
|
|
|
‡a
hdlandcardiovascularrisktimetocalltheplumber
‡A
HDL and cardiovascular risk: time to call the plumber?
‡9
1
|
919
|
|
|
‡a
myocardialinfarctionacceleratesbreastcancerviainnateimmunereprogramming
‡A
Myocardial infarction accelerates breast cancer via innate immune reprogramming
‡9
1
|
919
|
|
|
‡a
1signalinginatherosclerosissiblingrivalry
‡A
IL-1 signaling in atherosclerosis: sibling rivalry
‡9
1
|
919
|
|
|
‡a
evolutionarilyconservedrecognitionandinnateimmunitytofungalpathogensbythescavengerreceptorsscarf1andcd36
‡A
Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36
‡9
1
|
919
|
|
|
‡a
hdlpromotesrapidatherosclerosisregressioninmiceandaltersinflammatorypropertiesofplaquemonocytederivedcells
‡A
HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells
‡9
1
|
919
|
|
|
‡a
ldlreceptorpathwayregulationbymir224andmir520d
‡A
LDL Receptor Pathway Regulation by miR-224 and miR-520d
‡9
1
|
919
|
|
|
‡a
erratumnlrp3inflammasomesarerequiredforatherogenesisandactivatedbycholesterolcrystals
‡A
Erratum: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
‡9
1
|
919
|
|
|
‡a
enhancedglycolysisandhif1αactivationinadiposetissuemacrophagessustainslocalandsystemicinterleukin1βproductioninobesity
‡A
Enhanced glycolysis and HIF-1α activation in adipose tissue macrophages sustains local and systemic interleukin-1β production in obesity
‡9
1
|
919
|
|
|
‡a
emergingrolesofpcsk9morethana1trickpony
‡A
Emerging Roles of PCSK9: More Than a One-Trick Pony.
‡9
1
|
919
|
|
|
‡a
elixirsforrestraininginflammation
‡A
eLiXiRs for restraining inflammation
‡9
1
|
919
|
|
|
‡a
connectingtranscriptionalandfunctionalmacrophageheterogeneityinatherosclerosis
‡A
Connecting Transcriptional and Functional Macrophage Heterogeneity in Atherosclerosis
‡9
1
|
919
|
|
|
‡a
covid19andtheheartandvasculaturenovelapproachestoreducevirusinducedinflammationinpatientswithcardiovasculardisease
‡A
COVID-19 and the Heart and Vasculature: Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease
‡9
1
|
919
|
|
|
‡a
crosstalkbetweentheheartandcancerbeyonddrugtoxicity
‡A
Crosstalk Between the Heart and Cancer: Beyond Drug Toxicity
‡9
1
|
919
|
|
|
‡a
designermacrophagesoxidativemetabolismfuelsinflammationrepair
‡A
Designer macrophages: oxidative metabolism fuels inflammation repair
‡9
1
|
919
|
|
|
‡a
19haltsprogressionofatheroscleroticplaquepolarizesandincreasescholesteroluptakeandeffluxinmacrophages
‡A
IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages
‡9
1
|
919
|
|
|
‡a
dysfunctionalhdltakesitstollinchronickidneydisease
‡A
Dysfunctional HDL takes its toll in chronic kidney disease
‡9
1
|
919
|
|
|
‡a
commentaryonfattyacidwarsthediffusionistsversusthetranslocatists
‡A
Commentary on fatty acid wars: the diffusionists versus the translocatists.
‡9
1
|
919
|
|
|
‡a
reducedatherosclerosisinmyd88nullmicelinkselevatedserumcholesterollevelstoactivationofinnateimmunitysignalingpathways
‡A
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways
‡9
1
|
919
|
|
|
‡a
combinatorialpatternrecognitionreceptorsignalingaltersthebalanceoflifeanddeathinmacrophages
‡A
Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages.
‡9
1
|
919
|
|
|
‡a
roleoftolllikereceptor4inintimalfoamcellaccumulationinapolipoproteinedeficientmice
‡A
Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice
‡9
1
|
919
|
|
|
‡a
cholesteroleffluxpathwayssuppressinflammasomeactivationnetosisandatherogenesis
‡A
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis and Atherogenesis.
‡9
1
|
919
|
|
|
‡a
regulationofstressgranuleformationbyinflammationvascularinjuryandatherosclerosis
‡A
Regulation of Stress Granule Formation by Inflammation, Vascular Injury, and Atherosclerosis
‡9
1
|
919
|
|
|
‡a
cholesterolloadingreprogramsthemicrorna143145myocardinaxistoconvertaorticsmoothmusclecellstoadysfunctionalmacrophagelikephenotype
‡A
Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype
‡9
1
|
919
|
|
|
‡a
chemokinecxcl10promotesatherogenesisbymodulatingthelocalbalanceofeffectorandregulatorytcells
‡A
Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells
‡9
1
|
919
|
|
|
‡a
deletionofabca1andabcg1impairsmacrophagemigrationbecauseofincreasedrac1signaling
‡A
Deletion of ABCA1 and ABCG1 impairs macrophage migration because of increased Rac1 signaling
‡9
1
|
919
|
|
|
‡a
cd36signalstotheactincytoskeletonandregulatesmicroglialmigrationviaap130cascomplex
‡A
CD36 signals to the actin cytoskeleton and regulates microglial migration via a p130Cas complex.
‡9
1
|
919
|
|
|
‡a
eclecticcastofcellularactorsorchestratesinnateimmuneresponsesinthemechanismsdrivingobesityandmetabolicperturbation
‡A
An Eclectic Cast of Cellular Actors Orchestrates Innate Immune Responses in the Mechanisms Driving Obesity and Metabolic Perturbation
‡9
1
|
919
|
|
|
‡a
activationofcaspase1bythenlrp3inflammasomeregulatesthenadphoxidasenox2tocontrolphagosomefunction
‡A
Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function
‡9
1
|
919
|
|
|
‡a
antagonismofmir33inmicepromotesreversecholesteroltransportandregressionofatherosclerosis
‡A
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
‡9
1
|
919
|
|
|
‡a
storeoperatedca2+entrycontrolsinductionoflipolysisandthetranscriptionalreprogrammingtolipidmetabolism
‡A
Store-Operated Ca2+ Entry Controls Induction of Lipolysis and the Transcriptional Reprogramming to Lipid Metabolism
‡9
1
|
919
|
|
|
‡a
cd36ligandspromotesterileinflammationthroughassemblyofatolllikereceptor4and6heterodimer
‡A
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
‡9
1
|
919
|
|
|
‡a
singlestepreconstitutionofmultifunctionalhighdensitylipoproteinderivednanomaterialsusingmicrofluidics
‡A
Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics.
‡9
1
|
919
|
|
|
‡a
cd36mediatestheinnatehostresponsetobetaamyloid
‡A
CD36 mediates the innate host response to beta-amyloid
‡9
1
|
919
|
|
|
‡a
targetinginnateimmunityfor105benefit
‡A
Targeting Innate Immunity for CV Benefit
‡9
1
|
919
|
|
|
‡a
atherosclerosisandinnateimmunesignaling
‡A
Atherosclerosis and innate immune signaling.
‡9
1
|
919
|
|
|
‡a
heatshockprotein27attenuatesfoamcellformationandatherogenesisbydownregulatingscavengerreceptoraexpressionvianfκbsignaling
‡A
Heat shock protein-27 attenuates foam cell formation and atherogenesis by down-regulating scavenger receptor-A expression via NF-κB signaling
‡9
1
|
919
|
|
|
‡a
abca7nullmiceretainnormalmacrophagephosphatidylcholineandcholesteroleffluxactivitydespitealterationsinadiposemassandserumcholesterollevels
‡A
Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels.
‡9
1
|
919
|
|
|
‡a
cd36initiatedsignalingcascademediatesinflammatoryeffectsofbetaamyloid
‡A
A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid.
‡9
1
|
919
|
|
|
‡a
highcontentdrugscreenidentifiesursolicacidasaninhibitorofamyloidbetaproteininteractionswithitsreceptorcd36
‡A
A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36.
‡9
1
|
919
|
|
|
‡a
bigroleforsmallrnasinhdlhomeostasis
‡A
A big role for small RNAs in HDL homeostasis.
‡9
1
|
919
|
|
|
‡a
betaamyloidpromotesaccumulationoflipidperoxidesbyinhibitingcd36mediatedclearanceofoxidizedlipoproteins
‡A
beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins
‡9
1
|
919
|
|
|
‡a
heritablenetrin1mutationincreasesatherogenicimmuneresponses
‡A
A heritable netrin-1 mutation increases atherogenic immune responses
‡9
1
|
919
|
|
|
‡a
cd36coordinatesnlrp3inflammasomeactivationbyfacilitatingintracellularnucleationofsolubleligandsintoparticulateligandsinsterileinflammation
‡A
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
‡9
1
|
919
|
|
|
‡a
regulatorofsecretoryvesiclesizekelchlikeprotein12facilitatesthesecretionofapolipoproteinb100andverylowdensitylipoproteinsbriefreport
‡A
A regulator of secretory vesicle size, Kelch-like protein 12, facilitates the secretion of apolipoprotein B100 and very-low-density lipoproteins--brief report
‡9
1
|
919
|
|
|
‡a
vasculareffectsofalowcarbohydratehighproteindiet
‡A
Vascular effects of a low-carbohydrate high-protein diet.
‡9
1
|
919
|
|
|
‡a
endothelialexpressionofguidancecuesinvesselwallhomeostasisdysregulationunderproatheroscleroticconditions
‡A
Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions
‡9
1
|
919
|
|
|
‡a
divergentresponsetolpsandbacteriaincd14deficientmurinemacrophages
‡A
Divergent response to LPS and bacteria in CD14-deficient murine macrophages.
‡9
1
|
919
|
|
|
‡a
atpbindingcassettetransportera1containsannh2terminalsignalanchorsequencethattranslocatestheproteins1hydrophilicdomaintotheexoplasmicspace
‡A
ATP-binding cassette transporter A1 contains an NH2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space.
‡9
1
|
919
|
|
|
‡a
definingmacrophagesintheheart1cellatatime
‡A
Defining Macrophages in the Heart One Cell at a Time
‡9
1
|
919
|
|
|
‡a
atherogeniclipidsandlipoproteinstriggercd36tlr2dependentapoptosisinmacrophagesundergoingendoplasmicreticulumstress
‡A
Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
947
|
|
|
‡a
CA
‡9
1
|
996
|
|
|
‡2
DNB|1057808938
|
996
|
|
|
‡2
SUDOC|156531828
|
996
|
|
|
‡2
CAOONL|ncf11567212
|
996
|
|
|
‡2
NUKAT|n 01200823
|
996
|
|
|
‡2
N6I|vtls000060650
|
996
|
|
|
‡2
LC|n 2016062720
|
996
|
|
|
‡2
SUDOC|264062310
|
996
|
|
|
‡2
ISNI|0000000075600271
|
996
|
|
|
‡2
LC|n 2011016544
|
996
|
|
|
‡2
LC|nb2011010706
|
996
|
|
|
‡2
LC|n 99030702
|
996
|
|
|
‡2
BIBSYS|1560455411479
|
996
|
|
|
‡2
J9U|987007376232705171
|
996
|
|
|
‡2
LC|n 2004091407
|
996
|
|
|
‡2
LC|n 2002041053
|
996
|
|
|
‡2
LC|no2022102268
|
996
|
|
|
‡2
LC|no2018043835
|
996
|
|
|
‡2
LIH|LNB:BX_y_E;=B_u_
|
996
|
|
|
‡2
J9U|987007349624705171
|
996
|
|
|
‡2
NKC|mzk20191025315
|
996
|
|
|
‡2
DNB|1131386868
|
996
|
|
|
‡2
ISNI|000000002766553X
|
996
|
|
|
‡2
LC|n 80044347
|
996
|
|
|
‡2
N6I|vtls000290188
|
996
|
|
|
‡2
JPG|500281689
|
996
|
|
|
‡2
LC|n 88670804
|
996
|
|
|
‡2
ISNI|0000000047784712
|
996
|
|
|
‡2
CAOONL|ncf10252310
|
996
|
|
|
‡2
LC|no2021046899
|
996
|
|
|
‡2
BIBSYS|8082991
|
996
|
|
|
‡2
LC|no2022021766
|
996
|
|
|
‡2
SUDOC|258372931
|
996
|
|
|
‡2
LC|nb2004010851
|
996
|
|
|
‡2
LC|n 2022047063
|
996
|
|
|
‡2
NTA|338889272
|
996
|
|
|
‡2
NTA|440553172
|
996
|
|
|
‡2
ISNI|0000000108082360
|
996
|
|
|
‡2
BNF|16608955
|
996
|
|
|
‡2
CAOONL|ncf10572807
|
996
|
|
|
‡2
LC|n 2009026413
|
996
|
|
|
‡2
ISNI|0000000425543706
|
996
|
|
|
‡2
DNB|1156958814
|
996
|
|
|
‡2
ISNI|0000000046732638
|
996
|
|
|
‡2
SUDOC|235491403
|
996
|
|
|
‡2
PLWABN|9810632886805606
|
996
|
|
|
‡2
ISNI|0000000048554580
|
996
|
|
|
‡2
NDL|01242021
|
996
|
|
|
‡2
LC|n 00076119
|
996
|
|
|
‡2
ISNI|0000000119378511
|
996
|
|
|
‡2
LC|no2021067138
|
996
|
|
|
‡2
LC|n 85059331
|
996
|
|
|
‡2
NTA|188847324
|
996
|
|
|
‡2
CAOONL|ncf10283896
|
996
|
|
|
‡2
ISNI|0000000082553901
|
996
|
|
|
‡2
J9U|987009347744605171
|
996
|
|
|
‡2
ISNI|0000000107821600
|
996
|
|
|
‡2
DNB|139424113
|
996
|
|
|
‡2
LIH|LNB:DNY_h_;=B_p_
|
996
|
|
|
‡2
ISNI|0000000067512837
|
996
|
|
|
‡2
BIBSYS|8069962
|
996
|
|
|
‡2
ISNI|000000012368540X
|
996
|
|
|
‡2
LC|n 86831127
|
996
|
|
|
‡2
BIBSYS|1615360583267
|
996
|
|
|
‡2
ISNI|000000003795559X
|
996
|
|
|
‡2
ISNI|0000000074287850
|
996
|
|
|
‡2
LC|n 2016042447
|
996
|
|
|
‡2
LC|n 2021026079
|
996
|
|
|
‡2
J9U|987011050439505171
|
996
|
|
|
‡2
DNB|1230029362
|
996
|
|
|
‡2
NYNYRILM|261220
|
996
|
|
|
‡2
CAOONL|ncf11524397
|
996
|
|
|
‡2
CAOONL|ncf10602531
|
996
|
|
|
‡2
J9U|987007337719305171
|
996
|
|
|
‡2
LC|n 98880723
|
996
|
|
|
‡2
LC|n 93060029
|
996
|
|
|
‡2
DNB|1014106230
|
996
|
|
|
‡2
LC|n 2010075548
|
996
|
|
|
‡2
BIBSYS|1663836653015
|
996
|
|
|
‡2
LC|nb2001053966
|
996
|
|
|
‡2
LC|no2010077326
|
996
|
|
|
‡2
CAOONL|ncf11232984
|
996
|
|
|
‡2
LC|n 90657446
|
996
|
|
|
‡2
BNF|14040595
|
996
|
|
|
‡2
NII|DA05787336
|
996
|
|
|
‡2
NII|DA15148832
|
996
|
|
|
‡2
SUDOC|144121158
|
996
|
|
|
‡2
B2Q|0001101704
|
996
|
|
|
‡2
ISNI|0000000117783548
|
996
|
|
|
‡2
LC|no2024041161
|
996
|
|
|
‡2
NUKAT|n 2017241288
|
996
|
|
|
‡2
LC|no2020010784
|
996
|
|
|
‡2
ISNI|0000000031845971
|
996
|
|
|
‡2
ISNI|0000000040910915
|
996
|
|
|
‡2
ISNI|0000000483376344
|
996
|
|
|
‡2
DNB|132101521
|
996
|
|
|
‡2
W2Z|1615360583267
|
996
|
|
|
‡2
LC|no2006045823
|
996
|
|
|
‡2
LC|n 2008182898
|
996
|
|
|
‡2
J9U|987007364860205171
|
996
|
|
|
‡2
NTA|423099493
|
996
|
|
|
‡2
LC|nr2003026563
|
996
|
|
|
‡2
NYNYRILM|258104
|
996
|
|
|
‡2
LC|no2016038454
|
996
|
|
|
‡2
DNB|1069331945
|
996
|
|
|
‡2
LC|n 2010080158
|
996
|
|
|
‡2
VLACC|000042670
|
996
|
|
|
‡2
LC|no2011114090
|
996
|
|
|
‡2
NTA|413986039
|
996
|
|
|
‡2
BNF|18163030
|
996
|
|
|
‡2
BNF|17165465
|
996
|
|
|
‡2
J9U|987011561229405171
|
996
|
|
|
‡2
ISNI|0000000417328037
|
996
|
|
|
‡2
LC|no2011065564
|
996
|
|
|
‡2
LC|n 2003128102
|
996
|
|
|
‡2
ISNI|0000000050276698
|
996
|
|
|
‡2
DNB|188408347
|
996
|
|
|
‡2
PTBNP|1488180
|
996
|
|
|
‡2
SUDOC|077383761
|
996
|
|
|
‡2
NYNYRILM|192260
|
996
|
|
|
‡2
ISNI|0000000000872352
|
996
|
|
|
‡2
LC|no2022021767
|
996
|
|
|
‡2
LC|no 93020240
|
996
|
|
|
‡2
ISNI|0000000392781774
|
996
|
|
|
‡2
CAOONL|ncf13720427
|
996
|
|
|
‡2
CAOONL|ncf11488611
|
996
|
|
|
‡2
NTA|296940216
|
996
|
|
|
‡2
J9U|987007413116905171
|
996
|
|
|
‡2
NII|DA15775559
|
996
|
|
|
‡2
LC|nb2020008182
|
996
|
|
|
‡2
LC|n 2021033001
|
996
|
|
|
‡2
CAOONL|ncf10035586
|
996
|
|
|
‡2
LC|n 2024010238
|
996
|
|
|
‡2
ISNI|0000000076613760
|
996
|
|
|
‡2
ISNI|0000000499084821
|
996
|
|
|
‡2
CAOONL|ncf10349577
|
996
|
|
|
‡2
ISNI|0000000082424595
|
996
|
|
|
‡2
ISNI|0000000036304373
|
996
|
|
|
‡2
LC|n 2006183974
|
996
|
|
|
‡2
BAV|495_388715
|
996
|
|
|
‡2
RERO|A026981419
|
996
|
|
|
‡2
ISNI|0000000050361155
|
996
|
|
|
‡2
RERO|A027429812
|
996
|
|
|
‡2
LC|no2001044918
|
996
|
|
|
‡2
NUKAT|n 2019202985
|
996
|
|
|
‡2
N6I|vtls000091846
|
996
|
|
|
‡2
ISNI|0000000496799477
|
996
|
|
|
‡2
LIH|LNB:DR1_j_;=BX
|
996
|
|
|
‡2
ISNI|0000000035624914
|
996
|
|
|
‡2
W2Z|1663836653015
|
996
|
|
|
‡2
LC|no2021118736
|
996
|
|
|
‡2
LC|no2003090988
|
996
|
|
|
‡2
ISNI|0000000107920326
|
996
|
|
|
‡2
RERO|A027337092
|
996
|
|
|
‡2
PLWABN|9812831597505606
|
996
|
|
|
‡2
LC|no2017158983
|
996
|
|
|
‡2
SUDOC|236763881
|
996
|
|
|
‡2
NKC|ola2018985691
|
996
|
|
|
‡2
NTA|378124994
|
996
|
|
|
‡2
ISNI|0000000074083073
|
996
|
|
|
‡2
BIBSYS|1490965463457
|
996
|
|
|
‡2
BNF|17727188
|
996
|
|
|
‡2
LC|no2020098342
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|